Table 3 Serum hormone levels (median and interquartile range (IQR)) at Visit 12 for all women not using hormonal therapy, by self-reported vulvar pain symptoms at Visit 13
From: Chronic vulvar pain in a cohort of post-menopausal women: Atrophy or Vulvodynia?
Total | Current Chronic Vulvar Pain | Past/Short-term Vulvar Pain | No Vulvar Pain | ||
|---|---|---|---|---|---|
Variable | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | p-value |
Age (yr) | 61.3 (59.4-63.7) | 59.3 (58.6-60.4) | 61.4 (60.0-63.7) | 61.3 (59.4-63.7) | .23 |
Hormones (log transformed) | |||||
N = 319 | n = 12 | n = 38 | n = 264 | ||
E2 (average, pg/mL) | 19.8 (12.0-27.2) | 15.2 (3.7-24.4) | 23.2 (18.8-26.9) | 19.4 (12.0-27.3) | 0.06 |
DHEA-S (ug/dL) | 63.7 (36.8-88.6) | 28.5 (8.0-73.1) | 62.0 (49.3-83.2) | 65.0 (37.7-90.1) | 0.06 |
FSH (mIU/mL) | 52.2 (36.8-70.7) | 55.4 (38.7-64.6) | 52.7 (31.5-79.6) | 51.5 (36.9-70.6) | 0.92 |
SHBG (nM) | 48.8 (35.7-68.7) | 56.4 (31.8-94.1) | 53.1 (34.8-68.5) | 48.8 (35.8-67.8) | 0.83 |
T (ng/dL) | 49.8 (38.5-61.8) | 45.2 (22.5-54.9) | 54.7 (41.7-65.4) | 49.8 (38.7-61.6) | 0.22 |